John Whang
About John Whang
John Whang is the Vice President of Medical Affairs at Bristol Myers Squibb, with a background in leadership roles at Johnson & Johnson, Amgen, Real Endpoints, and McKinsey & Company.
Title
John Whang holds the position of Vice President, Medical Affairs at Bristol Myers Squibb. He has been with the company since May 2021 and operates in the New York City Metropolitan Area.
Current Role at Bristol Myers Squibb
In his role at Bristol Myers Squibb, John Whang is committed to delivering innovation and making a significant impact on patient care. His primary responsibilities involve overseeing medical affairs and ensuring that the organization's strategies are aligned with the latest medical advancements.
Previous Role at Johnson & Johnson
John Whang previously worked at Johnson & Johnson as Head of Integrated Evidence from 2017 to 2021. During his four-year tenure, he was responsible for integrating evidence to support healthcare decisions and improve patient outcomes.
Experience at Amgen
From 2014 to 2016, John Whang served as Executive Director, US Medical at Amgen. His responsibilities included leading medical affairs operations, contributing to the development of medical strategies, and supporting clinical research activities within the U.S.
Leadership at Real Endpoints
John Whang was the President of Real Endpoints from 2012 to 2014 before transitioning to an advisory role. As President, he oversaw the company's operations and strategy development, focusing on providing value-based insights and solutions for healthcare stakeholders.
Background at McKinsey & Company
Before his tenure at Real Endpoints, John Whang spent three years as a Senior Engagement Manager at McKinsey & Company in the Greater New York City Area. In this role, he managed client engagements, offering strategic insights and solutions in the healthcare sector.
Education and Expertise
John Whang achieved his Doctor of Medicine (MD) from Columbia University Vagelos College of Physicians and Surgeons. He also holds a Bachelor of Arts (AB) from Harvard University. His educational background and extensive experience in the medical field underpin his expertise and leadership in medical affairs.